Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression-Reference-Cited by-同舟云学术

Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression

Published:2019-12 Issue:6 Volume:52 Page:865-871
ISSN:1684-1182
Container-title:Journal of Microbiology, Immunology and Infection
language:en
Short-container-title:Journal of Microbiology, Immunology and Infection

Author:

Hung Tung-Che,Chen Guan-Jhou,Cheng Shu-Hsing^ORCID,Chen Jhen-Hong,Wei Jheng-Lun,Cheng Chien-Yu^ORCID,Hung Chien-Ching

Funder

Gilead Sciences

Merck

ViiV

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy

Reference34 articles.

1. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach;World Health Organization,2016

2. Adults and adolescents living with HIV guidelines for the use of antiretroviral agents in adults and adolescents living with HIV developed by the DHHS panel on antiretroviral guidelines for adults,2018

3. EACS European guidelines for treatment of HIV-positive adults in Europe,2018

4. Zidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity;Barry;Br J Clin Pharmacol,1994

5. Adverse effects of antiretroviral therapy;Carr;Lancet,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-Drug Regimens for HIV—Current Evidence, Research Gaps and Future Challenges;Microorganisms;2022-02-14

Impact of Medication Regimen Simplification on Medication Adherence and Clinical Outcomes in Patients with Long-Term Medical Conditions

;Patient Preference and Adherence;2020-11